Search Results - "de Miguel Novoa, Paz"
-
1
Isolated hypoaldosteronism is a cause of hypovolemic but not euvolemic hyponatremia
Published in Endocrine Connections (01-03-2024)“…Hypoaldosteronism is characterized by hyperkalemia, and/or hypovolemic hyponatremia (HH), often accompanied by metabolic acidosis. HH is typical of…”
Get full text
Journal Article -
2
An Integrated CT and MRI Imaging Model to Differentiate between Adrenal Adenomas and Pheochromocytomas
Published in Cancers (23-07-2023)“…to perform an external validation of our predictive model to rule out pheochromocytoma (PHEO) based on unenhanced CT in a cohort of patients with PHEOs and…”
Get full text
Journal Article -
3
Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice
Published in Frontiers in endocrinology (Lausanne) (11-10-2022)“…Hypoaldosteronism can be congenital or acquired, isolated or part of primary adrenal insufficiency, and caused by an aldosterone deficit, resistance, or a…”
Get full text
Journal Article -
4
Risk factors for intraoperative complications in pheochromocytomas
Published in Endocrine-related cancer (01-11-2021)“…We aimed to identify presurgical and surgical risk factors for intraoperative complications in patients with pheochromocytomas. A retrospective study of…”
Get full text
Journal Article -
5
Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas
Published in Endocrine-related cancer (01-12-2022)“…The objective of our study was to determine the prevalence of glycemic disorders (diabetes mellitus and prediabetes) in patients with pheochromocytomas and…”
Get full text
Journal Article -
6
Genetic Study in Pheochromocytoma: Is It Possible to Stratify the Risk of Hereditary Pheochromocytoma?
Published in Neuroendocrinology (01-05-2023)“…It is estimated that 30-40% of patients with apparently sporadic pheochromocytomas (PHEOs) have an inherited predisposition syndrome. The aim of our study was…”
Get more information
Journal Article -
7
Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues
Published in European journal of endocrinology (01-01-2013)“…ObjectiveMost cases of familial isolated pituitary adenomas with mutated aryl hydrocarbon receptor-interacting protein (AIP:HGNC:358) gene develop…”
Get full text
Journal Article -
8
Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic from Euvolemic Hyponatremia
Published in Medicina (Kaunas, Lithuania) (25-06-2022)“…Background and Objectives: Differentiating between hypovolemic (HH) and euvolemic hyponatremia (EH) is crucial for correct diagnosis and therapy, but can be a…”
Get full text
Journal Article -
9
ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly
Published in Endocrinologia, diabetes y nutricion (01-05-2019)“…The ACROSTART study was intended to determine the time to achieve normalization of GH and IGF-I levels in responding patients with acromegaly administered…”
Get full text
Journal Article -
10
RISK FACTORS FOR INTRAOPERATIVE AND POSTSURGICAL HYPERTENSIVE CRISIS IN PATIENTS WITH PHEOCHROMOCYTOMAS AND SYMPATHETIC PARAGANGLIOMAS: RESULTS FROM THE PHEO-RISK STUDY
Published in Journal of hypertension (01-06-2023)“…Objective: To identify presurgical and surgical risk factors for intraoperative and postoperative hypertensive crisis in patients with pheochromocytomas and…”
Get full text
Journal Article -
11
Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas
Published in Journal of hypertension (01-02-2024)“…To identify presurgical and surgical risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas…”
Get full text
Journal Article -
12
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis
Published in Frontiers in endocrinology (Lausanne) (30-11-2020)“…Dysnatremia is associated with increased mortality in patients with community-acquired pneumonia. SARS-COV2 (Severe-acute-respiratory syndrome caused by…”
Get full text
Journal Article -
13
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics
Published in The Journal of molecular diagnostics : JMD (01-07-2017)“…Genetic diagnosis is recommended for all pheochromocytoma and paraganglioma (PPGL) cases, as driver mutations are identified in approximately 80% of the cases…”
Get full text
Journal Article -
14
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Published in Endocrine-related cancer (01-07-2024)“…The objective of the study was to evaluate the efficacy of second-line therapies in patients with acromegaly caused by a growth hormone (GH) and prolactin…”
Get more information
Journal Article -
15
Predictive model of pheochromocytoma based on the imaging features of the adrenal tumours
Published in Scientific reports (17-02-2022)“…The purpose of our study was to develop a predictive model to rule out pheochromocytoma among adrenal tumours, based on unenhanced computed tomography (CT)…”
Get full text
Journal Article -
16
Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas
Published in Frontiers in endocrinology (Lausanne) (07-12-2023)“…To evaluate the rate of recurrence among patients with pheochromocytomas and sympathetic paragangliomas (PGLs; together PPGLs) and to identify predictors of…”
Get full text
Journal Article -
17
SEEN guidelines for the management and prevention of acute adrenal insufficiency
Published in Endocrinología, diabetes y nutrición. (01-01-2020)“…Acute adrenal insufficiency (AAI) is a potentially fatal medical emergency whose prevention and treatment should be known by all medical professionals. AAI is…”
Get full text
Journal Article -
18
The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
Published in The journal of clinical endocrinology and metabolism (01-01-2010)“…Context: The deletion of exon 3 in the GH receptor (GHR) has been associated with a different biochemical picture and response to therapy in acromegaly…”
Get full text
Journal Article -
19
Gastroenteropancreatic neuroendocrine tumors: clinical characteristics, diagnosis and prognosis at Hospital Universitario Clínico San Carlos (Madrid)
Published in Endocrinologia y nutricion (01-05-2014)“…Neuroendocrine tumors are a group of neoplasms arising from the neural crest and endoderm and very heterogeneous as regards localization, clinical behavior,…”
Get more information
Journal Article -
20
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
Published in European journal of endocrinology (01-04-2009)“…ContextPegvisomant is an effective treatment for somatostatin analogue-resistant acromegaly, but the determinants defining the response to this treatment are…”
Get full text
Journal Article